Cayuga Biotech, Inc.
Cayuga Biotech is dedicated to harnessing the body's innate ability to halt bleeding and promote healing through innovative biomimetic therapies. The company develops proprietary science-based solutions, including polyphosphate-based therapies, to address significant unmet needs in hemorrhage control and bleeding disorders. Their mission is to improve survival outcomes in life-threatening hemorrhage and advance treatment options for bleeding disorders.
Industries
Nr. of Employees
small (1-50)
Cayuga Biotech, Inc.
500 Eighth Avenue, Front 3, # 1596, New York, NY 10018
Products
Optimized polyphosphate-derived systemic injectable hemostatic therapy (lead program, late preclinical)
An optimized formulation of short-chain polyphosphate complexed with nanoparticles developed for systemic administration to accelerate hemostatic control in acute major hemorrhage (intended for non-compressible bleeding sites).
Discovery-stage polyphosphate-derived composition for inherited bleeding disorders
A discovery-stage composition based on polyphosphate chemistry being explored as a potential treatment approach for inherited bleeding disorders.
Optimized polyphosphate-derived systemic injectable hemostatic therapy (lead program, late preclinical)
An optimized formulation of short-chain polyphosphate complexed with nanoparticles developed for systemic administration to accelerate hemostatic control in acute major hemorrhage (intended for non-compressible bleeding sites).
Discovery-stage polyphosphate-derived composition for inherited bleeding disorders
A discovery-stage composition based on polyphosphate chemistry being explored as a potential treatment approach for inherited bleeding disorders.
Services
Engagements for investment, development partnerships, licensing discussions and collaborative development of hemorrhage and bleeding-disorder therapeutics.
Engagements for investment, development partnerships, licensing discussions and collaborative development of hemorrhage and bleeding-disorder therapeutics.
Expertise Areas
- Hemostasis and hemorrhage therapeutics
- Preclinical hemorrhage model testing
- Nanoparticle–polymer formulation for systemic delivery
- Translational medicine and drug discovery
Key Technologies
- Polyphosphate-based therapeutics
- Silica nanoparticle–polymer complexation
- Systemic injectable drug delivery
- In vitro coagulation assays (clotting kinetics)